Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks.
Fonseca E, Olivé-Cirera G, Martinez-Hernandez E, Guasp M, Naranjo L, Ruiz-García R, Caballero E, González-Álvarez V, Delgadillo V, Romeu G, Del-Prado-Sánchez C, Cabrera-Maqueda JM, Benito-León J, Iñiguez C, Garcia-Dominguez JM, Calles C, Cano A, Álvarez-Bravo G, González-Suárez I, Oreja-Guevara C, Ros M, Millan-Pascual J, Meca-Lallana JE, Borrega Canelo L, Martín-Martínez J, Palao M, Gracia J, Villaverde-González R, Llufriu S, Blanco Y, Saiz A, Dalmau J, Sepulveda M, Armangue T; Spanish MOGAD study group. Fonseca E, et al. Among authors: cano a. Neurology. 2024 Sep 24;103(6):e209682. doi: 10.1212/WNL.0000000000209682. Epub 2024 Aug 27. Neurology. 2024. PMID: 39190859
[Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia].
Otero S, Batlle J, Bonaventura I, Brieva L, Bufill E, Cano A, Carmona O, Escartín A, Marco M, Moral E, Munteis E, Nos C, Pericot I, Perkal H, Ramió-Torrentà L, Ramo-Tello C, Saiz A, Sastre-Garriga J, Tintoré M, Vaqué J, Montalban X; Grupo de Trabajo del Registro de Esclerosis Múltiple de Cataluña. Otero S, et al. Among authors: cano a. Rev Neurol. 2010 May 16;50(10):623-33. Rev Neurol. 2010. PMID: 20473839 Free article. Spanish.
Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.
Morató X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, Montrreal L, Rosende-Roca M, García-González P, Olivé C, García-Gutiérrez F, Blázquez J, Miguel A, Núñez-Llaves R, Pytel V, Alegret M, Fernández MV, Marquié M, Valero S, Cavazos JE, Mañes S, Boada M, Cabrera-Socorro A, Ruiz A. Morató X, et al. Among authors: cano a. Brain Behav Immun Health. 2024 Nov 16;42:100899. doi: 10.1016/j.bbih.2024.100899. eCollection 2024 Dec. Brain Behav Immun Health. 2024. PMID: 39640195 Free PMC article.
Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study).
Machuca I, Dominguez A, Amaya R, Arjona C, Gracia-Ahufinger I, Carralon M, Giron R, Gea I, De Benito N, Martin A, Galan F, Martinez JA, Iglesias R, Revuelto J, Caston JJ, Cano A, Ruiz-Arabi E, Martínez-Martínez L, Torre-Cisneros J. Machuca I, et al. Among authors: cano a. Infect Dis Ther. 2024 Nov 29. doi: 10.1007/s40121-024-01077-z. Online ahead of print. Infect Dis Ther. 2024. PMID: 39612160
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.
Tonietto M, Sotolongo-Grau O, Roé-Vellvé N, Bullich S, Tartari JP, Sanabria Á, García-Sánchez A, Borroni E, Galli C, Pérez-Martínez E, Castell-Conesa J, Roca I, Tárraga L, Ruiz A, Stephens AW, Boada M, Klein G, Marquié M; FACEHBI study group; AMYPAD consortium. Tonietto M, et al. Alzheimers Res Ther. 2024 Nov 28;16(1):257. doi: 10.1186/s13195-024-01622-5. Alzheimers Res Ther. 2024. PMID: 39605030 Free PMC article.
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.
Schaudig K, Wang X, Bouchard C, Hirschberg AL, Cano A, Shapiro C M M, Stute P, Wu X, Miyazaki K, Scrine L, Nappi RE. Schaudig K, et al. Among authors: cano a. BMJ. 2024 Nov 18;387:e079525. doi: 10.1136/bmj-2024-079525. BMJ. 2024. PMID: 39557487 Free PMC article. Clinical Trial.
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.
Castilla-Martí L, García-Sánchez A, Martínez J, Rosende-Roca M, Vargas L, Tartari JP, Casales F, Rodríguez JN, Bein N, Alegret M, Ortega G, Espinosa A, Sanabria Á, Pérez-Cordón A, Muñoz N, García-Gutiérrez F, Blazquez-Folch J, Miguel A, de Rojas I, García-González P, Puerta R, Olivé C, Capdevila M, Muñoz-Morales Á, Bayón-Buján P, Cano A, Fernández V, Valero S, Tárraga L, Ruiz A, Boada M, Castilla-Martí M, Marquié M. Castilla-Martí L, et al. Among authors: cano a. Alzheimers Res Ther. 2024 Nov 16;16(1):249. doi: 10.1186/s13195-024-01616-3. Alzheimers Res Ther. 2024. PMID: 39550564 Free PMC article.
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits.
Wang C, Yang C, Western D, Ali M, Wang Y, Phuah CL, Budde J, Wang L, Gorijala P, Timsina J, Ruiz A, Pastor P, Fernandez MV; Dominantly Inherited Alzheimer Network (DIAN); Alzheimer’s Disease Neuroimaging Initiative (ADNI); Panyard DJ, Engelman CD, Deming Y, Boada M, Cano A, Garcia-Gonzalez P, Graff-Radford NR, Mori H, Lee JH, Perrin RJ, Ibanez L, Sung YJ, Cruchaga C. Wang C, et al. Among authors: cano a. Nat Genet. 2024 Dec;56(12):2685-2695. doi: 10.1038/s41588-024-01973-7. Epub 2024 Nov 11. Nat Genet. 2024. PMID: 39528826
1,198 results